本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BriaCell Therapeutics Corp.

0.7720
-1.2480-61.78%
盘后0.77600.0040+0.52%16:01 EDT
成交量:2,270.77万
成交额:3,457.69万
市值:523.11万
市盈率:-0.11
高:2.02
开:1.97
低:0.6900
收:2.02
数据加载中...
2022/10/28

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/10/21

重要事件披露

8-K - Current report
2022/09/14

重要事件披露

8-K - Current report
2022/08/04

重要事件披露

8-K - Current report
2022/08/01

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/04/25

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/20

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/16

[修订]年度报告

40-F/A [Amend] - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2021/10/29

年度报告

40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2021/09/20

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/09/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/09/07

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/08/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/08/09

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership